Japan Tobacco Inc.   Report issue

Contributed to NME For profit Phase 2
Founded: Tokyo Japan (1985)

Organization Overview

First Clinical Trial
2000
NCT00686010
First Marketed Drug
2005
elvitegravir (vitekta)
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Japan Tobacco Inc.